<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01410279</url>
  </required_header>
  <id_info>
    <org_study_id>09032</org_study_id>
    <nct_id>NCT01410279</nct_id>
  </id_info>
  <brief_title>Inspiratory Muscle Training in Pulmonary Hypertension</brief_title>
  <official_title>Inspiratory Muscle Training Effect on the Functional Capacity and the Quality of Life in Chronic Pulmonary Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Clinicas de Porto Alegre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Associação Fundo de Incentivo à Pesquisa</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Conselho Nacional de Desenvolvimento Científico e Tecnológico</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital de Clinicas de Porto Alegre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is evaluate the effect the inspiratory muscle training on the
      functional capacity of patients with pulmonary hypertension.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pulmonary hypertension (PH) is a syndrome, in the case of hemodynamic alteration of a number
      of diseases and processes, such as the progressive increase in pulmonary vascular resistance,
      right heart failure and early death. Frequently patients with PH have reduced functional
      capacity, quality of life and survival. It was demonstrated recently that patients with HP
      also have inspiratory muscle weakness, possibly further increase the fatigue and dyspnea
      during exercise. To meet this need, inspiratory muscle training can lead to significant
      improvement in respiratory muscle strength, exercise tolerance and dyspnea, thus resulting in
      reduction of discomfort during activities of daily living, increase in exercise capacity and
      improved quality of life in different situations.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2009</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The distance traveled in meters in the six minutes walk test after 8 weeks the inspiratory muscle training</measure>
    <time_frame>patients will be monitored throughout the training protocol for 8 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Increase in score of quality of life questionnaire after 8 weeks the inspiratory muscle training</measure>
    <time_frame>patients will be monitored throughout the training protocol for 8 weeks</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Pulmonary Hypertension</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inspiratory muscle training</intervention_name>
    <description>The load is adjusted weekly in thirty percent of maximal inspiratory pressure of the subject.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis pulmonary hypertension

          -  World Health Organization (WHO) functional class II to IV

          -  inspiratory muscle weakness

        Exclusion Criteria:

          -  obesity

          -  chronic obstructive pulmonary disease

          -  orthopedic and neurological disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pedro Dal'Lago</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital de Clínicas de Porto Alegre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pedro Dal'Lago</last_name>
    <phone>55(51)3303-8796</phone>
    <email>pdallago@ufcspa.edu.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Glória M Ferreira</last_name>
    <phone>55(51)9284.0703</phone>
    <email>glomenz@yahoo.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de Clinica de Porto Alegre</name>
      <address>
        <city>Porto Alegre</city>
        <state>Rio Grande do Sul</state>
        <zip>90035003</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pedro Dal'Lago</last_name>
      <phone>+55(51)3303-8796</phone>
      <email>pdallago@ufcspa.edu.br</email>
    </contact>
    <contact_backup>
      <last_name>Glória M Ferreira</last_name>
      <phone>+55(51)9284-0703</phone>
      <email>glomenz@yahoo.com.br</email>
    </contact_backup>
    <investigator>
      <last_name>Pedro Dal'Lago</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Glória M Ferreira</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sérgio M Barreto</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <results_reference>
    <citation>Dall'Ago P, Chiappa GR, Guths H, Stein R, Ribeiro JP. Inspiratory muscle training in patients with heart failure and inspiratory muscle weakness: a randomized trial. J Am Coll Cardiol. 2006 Feb 21;47(4):757-63. Epub 2006 Jan 26.</citation>
    <PMID>16487841</PMID>
  </results_reference>
  <results_reference>
    <citation>Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, Meyer FJ, Karger G, Buss J, Juenger J, Holzapfel N, Opitz C, Winkler J, Herth FF, Wilkens H, Katus HA, Olschewski H, Grünig E. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation. 2006 Oct 3;114(14):1482-9. Epub 2006 Sep 18.</citation>
    <PMID>16982941</PMID>
  </results_reference>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 20, 2011</study_first_submitted>
  <study_first_submitted_qc>August 4, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2011</study_first_posted>
  <last_update_submitted>August 4, 2011</last_update_submitted>
  <last_update_submitted_qc>August 4, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 5, 2011</last_update_posted>
  <responsible_party>
    <name_title>Pedro Dal'Lago</name_title>
    <organization>UFCSPA</organization>
  </responsible_party>
  <keyword>pulmonary hypertension</keyword>
  <keyword>inspiratory muscle training</keyword>
  <keyword>inspiratory muscle weakness</keyword>
  <keyword>pulmonary functional</keyword>
  <keyword>functional capacity</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

